SVEP1 expression is regulated in estrogen-dependent manner

Journal of Cellular Physiology

Volumn 210, Issue 3, 2007, Pages 732-739

  Shur, I ^a   Zemer Tov, E ^a   Socher, R ^a   Benayahu, D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL SURFACE PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; PROTEIN SVEP1; SELECTIN; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; BONE METASTASIS; BREAST CARCINOMA; CANCER CELL CULTURE; CELL CULTURE; CELL INTERACTION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESTROGEN ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SVEP1 GENE;

ANIMALS; BONE MARROW; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RATS; RNA, MESSENGER; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

RATTUS;

EID: 33846649566     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20895     Document Type: Article

References (64)

1. Askenasy N, Zorina T, Farkas DL, Shalit I. 2002. Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivo. Stem Cells 20:301-310.
2. Azios NG, Dharmawardhane SF. 2005. Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia 7:128-140.
3. Aziz KE, Wakefield D. 1996. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-estradiol, progesterone, and dexamethasone. Cell Immunol 167:79-85.
4. Bell CD, Tischler EM, Laroye GJ. 1995. The relationship of cytoplasmic intermediate filaments and membrane antigens with hormone receptors, nuclear staining density, and mode of stromal invasion in human breast cancer. Breast Cancer Res Treat 33:147-162.
5. Beloti MM, Bellesini LS, de Oliveira PT, Rosa AL. 2006. Participation of estrogen receptors in the enhancement of osteoblast differentiation by TAK-778. Mol Cell Biochem 285:101-109.
6. Benayahu D. 1997. Estrogen effects on protein expressed by marrow stromal osteoblasts. Biochem Biophys Res Commun 233(1):30-35.
7. Benayahu D, Shur I, Ben-Eliyahu S. 2000. Hormonal changes affect the bone and bone marrow cells in a rat model. J Cell Biochem 79:407-415.
8. Brigstock DR. 2003. The CCN family: A new stimulus package. J Endocrinol 178:169-175.
9. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425:841-846.
10. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. 1996. Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98:36-42.
11. Cenci S, Toraldo G, Weitzmann MN, Roggia C, Gao Y, Qian WP, Sierra O, Pacific: R. 2003. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. Proc Natl Acad Sci USA 100:10405-10410.
12. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS. 1994. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, vascular cell adhesion molecule type. J Clin Invest 93:17-25.
13. Colombatti A, Bonaldo P, Doliana R. 1993. Type A modules: Interacting domains found in several non-fibrillar collagens and in other extracellular matrix proteins. Matrix 13:297-306.
14. Driscoll MD, Sathya G, Muyan M, Klinge CM, Hilf R, Bambara RA. 1998. Sequence requirements for estrogen receptor binding to estrogen response elements. J Biol Chem 273:29321-29330.
15. Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM, Rodan GA. 1998. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. J Clin Invest 102:881-892.
16. Erlandsson MC, Jonsson CA, Lindberg MK, Ohlsson C, Carlsten H. 2002. Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice. J Endocrinol 175:319-327.
17. Gourdy P, Mallat Z, Castano C, Garmy-Susini B, Mac Gregor JL, Tedgui A, Arnal JF, Bayard F. 2003. The atheroprotective effect of 17 beta-estradiol is not altered in P-selectin- or ICAM-1-deficient hypercholesterolemic mice. Atherosclerosis 166:41-48.
18. Gu G, Hentunen TA, Nars M, Harkonen PL, Vaananen HK. 2005. Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis 10:583-595.
19. Ishihara A, Sasaki T, Debari K, Furuya R, Kawawa T, Ramamurthy NS, Golub LM. 1999. Effects of ovariectomy on bone morphology in maxillae of mature rats. J Electron Microsc 48:465-469.
20. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF. 2000. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275:9645-9652.
21. Kansas GS. 1996. Selectins and their ligands: Current concepts and controversies. Blood 88:3259-3287.
22. Klinge CM. 2001. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 29:2905-2919.
23. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb P. 2000. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol 74:311-317.
24. Labrador JP, Brambilla R, Klein R. 1997. The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling. EMBO J 16:3889-3897.
25. Lieberherr M, Grosse B, Kachkache M, Balsan S. 1993. Cell signaling and estrogens in female rat osteoblasts: A possible involvement of unconventional nonnuclear receptors. J Bone Miner Res 8:1365-1376.
26. Liu Z, Graff E, Benayahu D. 2000. Effect of raloxifene-analog (LY 117018-Hcl) on the bone marrow of ovariectomized mice. J Cell Biochem 76:509-517.
27. Manolagas SC, Kousteni S, Jilka RL. 2002. Sex steroids and bone. Recent Prog Horm Res 57:385-409.
28. Massas R, Korenstein R, Benayahu D. 1998. Estrogen modulation of osteoblastic cell-to-cell communication. J Cell Biochem 69:282-290.
29. Mendelsohn ME, Karas RH. 1999. The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811.
30. Moggs JG, Orphanides G. 2001. Estrogen receptors: Orchestrators of pleiotropic cellular responses. EMBO Rep 2:775-781.
31. Moggs JG, Deavall DG, Orphanides G. 2003. Sex steroids, ANGELS and osteoporosis. Bioessays 25:195-199.
32. Monroe DG, Spelsberg TC. 2003. A case for estrogen receptors on cell membranes and nongenomic actions of estrogen. Calcif Tissue Int 72:183-184.
33. Monroe DG, Secreto FJ, Hawse JR, Subramaniam M, Khosla S, Spelsberg TC. 2006. Estrogen receptor isoform-specific regulation of the retinoblastoma binding protein 1 (RBBP1) gene: Roles of AF1 and enhancer elements. J Biol Chem 281(39):28596-28604.
34. Neiva K, Sun YX, Taichman RS. 2005. The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasis. Braz J Med Biol Res 38:1449-1454.
35. Onoe Y, Miyaura C, Ito M, Ohta H, Nozawa S, Suda T. 2000. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res 15:541-549.
36. Parker MG. 1998. Transcriptional activation by oestrogen receptors. Biochem Soc Symp 63:45-50.
37. Patel KD, Cuvelier SL, Wiehler P. 2002. Selectins: Critical mediators of leukocyte recruitment. Immunology 14:73-81.
38. Petz LN, Nardulli AM. 2000. Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol Endocrinol 14:972-985.
39. Petz LN, Ziegler YS, Loven MA, Nardulli AM. 2002. Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells. Endocrinology 143:4583-4591.
40. Plant A, Tobias JH. 2001. Characterisation of the temporal sequence of osteoblast gene expression during estrogen-induced osteogenesis in female mice. J Cell Biochem 82:683-691.
41. Plant A, Samuels A, Perry MJ, Colley S, Gibson R, Tobias JH. 2002. Estrogen-induced osteogenesis in mice is associated with the appearance of Cbfa1-expressing bone marrow cells. J Cell Biochem 84:285-294.
42. Plotkin LI, Manolagas SC, Bellido T. 2002. Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 277:8648-8657.
43. Porter W, Saville B, Hoivik D, Safe S. 1997. Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580.
44. Rickard DJ, Subramaniam M, Spelsberg TC. 1999. Molecular and cellular mechanisms of estrogen action on the skeleton. J Cell Biochem Suppl 32-33:123-132.
45. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R. 2001. Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98:13960-13965.
46. Safe S. 2001. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252.
47. Saintier D, Burde MA, Rey JM, Maudelonde T, De Vernejoul MC, ME C-S. 2004. 17b-Estradiol downregulates b3-integrin expression in differentiating and mature human osteoclasts. J Cell Physiol 198:269-276.
48. Sanchez H, Nguyen D, Rocha W, White JH, Mader S. 2002. Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays 24:244-254.
49. Sarrio D, Rodriguez-Pinilla SM, Dotor A, Calero F, Hardisson D, Palacios J. 2006. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat 98:71-79.
50. Sathya G, Li W, Klinge CM, Anolik JH, Hilf R, Bambara RA. 1997. Effects of multiple estrogen responsive elements, their spacing, and location on estrogen response of reporter genes. Mol Endocrinol 11:1994-2003.
51. Shamay A, Knopov V, Benayahu D. 1996. The expression of estrogen receptor and estrogen effect in MBA-15 marrow stromal osteoblasts. Cell Biol Int 20:401-405.
52. Shi S, Gronthos S. 2003. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18:696-704.
53. Shur I, Marom R, Lokiec F, Socher R, Benayahu D. 2002. Identification of cultured progenitor cells from human marrow stroma. J Cell Biochem 87:51-57.
54. Shur I, Socher R, Hameiri M, Fried A, Benayahu D. 2006. Molecular and cellular characterization of SEL-OB/SVEP1 in osteogenic cells in vivo and in vitro. J Cell Physiol 206:420-427.
55. Spelsberg TC, Subramaniam M, Riggs BL, Khosla S. 1999. The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. Mol Endocrinol 13:819-828.
56. Stork S, von Schacky C, Angerer P. 2002. The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: A randomized, controlled trial. Atherosclerosis 165:301-307.
57. Tobias JH. 1999. The effects of SERMs on the skeleton. J Endocrinol Invest 22:604-608.
58. Vyhlidal C, Samudio I, Kladde MP, Safe S. 2000. Transcriptional activation of transforming growth factor alpha by estradiol: Requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol 24:329-338.
59. Watts NB. 2000. Focus on primary care postmenopausal osteoporosis: An update. Obstet Gynecol Surv 55:349-55.
60. Wessel GM, Berg L, Adelson DL, Cannon G, McClay DR. 1998. A molecular analysis of hyalin-A substrate for cell adhesion in the hyaline layer of the sea urchin embryo. Dev Biol 193:115-126.
61. Wiren KM, Toombs AR, Semirale AA, Zhang X. 2006. Osteoblast and osteocyte apoptosis associated with androgen action in bone: Requirement of increased Bax/Bcl-2 ratio. Bone 38:637-651.
62. Wren BG. 1992. The effect of oestrogen on the female cardiovascular system. Med J Aust 157:204-208.
63. Zeitlin L, Segev E, Fried A, Wientroub S. 2003. Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice. J Cell Biochem 90:347-360.
64. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425:836-841.